StreetInsider.com News Articles

Modular Medical and IMO Health pilot insulin pump patient ID tool

Thu, 16 Jul 2026 08:02:14 -0400

Modular Medical, Inc. (NASDAQ: MODD) and IMO Health have announced a pilot collaboration aimed at developing a terminology-powered algorithm to identify diabetes patients who may benefit from insulin pump therapy within electronic health records (EHR).

The pilot targets multiple-daily-injection patients who show clinical characteristics linked to insulin pump hesitancy or prior pump failure. Using IMO Health's clinical terminology identifiers combined with clinician-guided phenotypes, the tool is designed to surface eligible patients during routine clinical visits and reduce the burden of manual chart review.

IMO Health will translate defined clinical characteristics into validated terminology value sets that capture physician intent when documenting symptoms,

Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records

Thu, 16 Jul 2026 08:00:00 -0400

Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump Therapy
Advancing Towards Fourth Quarter Commercial Launch of Pivot Pump

SAN DIEGO, CA AND ROSEMONT, IL / ACCESS Newswire / July 16, 2026 / Modular Medical, Inc., ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, today announced an important pilot collaboration with IMO Health, whose expert-curated clinical terminology and accountable healthcare AI solutions

Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records

Thu, 16 Jul 2026 08:00:00 -0400

Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump Therapy
Advancing Towards Fourth Quarter Commercial Launch of Pivot Pump

Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump

Wed, 15 Jul 2026 08:00:00 -0400

Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towards goal of achieving broad market access for Pivot

SAN DIEGO, CA / ACCESS Newswire / July 15, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today released findings from an independent market research study demonstrating positive receptivity to its FDA-cleared Pivot^™ tubeless patch pump due to its differentiated design, streamlined

Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump

Wed, 15 Jul 2026 08:00:00 -0400

Modular Medical survey finds high pump therapy interest among injection users

Tue, 14 Jul 2026 08:04:27 -0400

Modular Medical, Inc. (NASDAQ: MODD) released findings from a research initiative showing that 97% of surveyed insulin injection users expressed interest in insulin pump therapy, according to a company press release.

The survey assessed 100 individuals using multiple daily injections. Among participants, 43% reported being hospitalized due to diabetes-related complications, with nearly half of that group experiencing such events two or more times per year. Additionally, 55% reported finding themselves in inconvenient or non-private situations for administering injections at least twice per week.

The San Diego-based company said the findings support its commercialization of the Pivot tubeless insulin patch pump, a wearable

Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery

Tue, 14 Jul 2026 08:00:00 -0400

97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes

Conducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless Insulin Patch Pump

Company to Showcase Pivot at Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, August 7-10, 2026

SAN DIEGO, CA / ACCESS Newswire / July 14, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today announced positive findings from a new comprehensive diabetes

Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery

Tue, 14 Jul 2026 08:00:00 -0400

97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes

Conducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless Insulin Patch Pump

Company to Showcase Pivot at Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, August 7-10, 2026

Form 4 Modular Medical, Inc. For: Jun 30 Filed by: Sheibley Philip Brent

Thu, 02 Jul 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260702/26728485.html

Form 4 Modular Medical, Inc. For: Jun 30 Filed by: Sheibley Philip Brent

Thu, 02 Jul 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260702/26728485.html

Form 4 Modular Medical, Inc. For: Jun 30 Filed by: Vos Ellen O'Connor

Thu, 02 Jul 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260702/26728499.html

Form 4 Modular Medical, Inc. For: Jun 30 Filed by: Vos Ellen O'Connor

Thu, 02 Jul 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260702/26728499.html

Form 4 Modular Medical, Inc. For: Jun 30 Filed by: DeSisto Duane M